ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Orchestra BioMed Holdings Inc

Orchestra BioMed Holdings Inc (OBIO)

5.4015
-0.0385
( -0.71% )
Updated: 04:47:21

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
5.4015
Bid
5.32
Offer
5.45
Volume
24,087
5.30 Day's Range 5.47
3.96 52 Week Range 10.0631
Market Cap
Previous Close
5.44
Open
5.47
Last Trade
4
@
5.44
Last Trade Time
04:49:35
Financial Volume
US$ 131,180
VWAP
5.4461
Average Volume (3m)
101,128
Shares Outstanding
38,013,526
Dividend Yield
-
PE Ratio
-4.18
Earnings Per Share (EPS)
-1.29
Revenue
2.76M
Net Profit
-49.12M

About Orchestra BioMed Holdings Inc

Health Sciences Acquisitions Corp 2 is a blank check company. Health Sciences Acquisitions Corp 2 is a blank check company.

Sector
Surgical,med Instr,apparatus
Industry
Blank Checks
Headquarters
Grand Cayman, Cym
Founded
2023
Orchestra BioMed Holdings Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker OBIO. The last closing price for Orchestra BioMed was US$5.44. Over the last year, Orchestra BioMed shares have traded in a share price range of US$ 3.96 to US$ 10.0631.

Orchestra BioMed currently has 38,013,526 shares in issue. The market capitalisation of Orchestra BioMed is US$206.79 million. Orchestra BioMed has a price to earnings ratio (PE ratio) of -4.18.

OBIO Latest News

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

NEW HOPE, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies...

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...

Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances

NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in developing brain–computer interface technology to restore function and autonomy for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2985-5.236842105265.75.795847615.37489775CS
40.761516.4116379314.646.33.962006765.26220258CS
12-0.6085-10.12479201336.016.53.961011285.39181144CS
26-3.0785-36.30306603778.488.86993.96801165.68465817CS
52-1.6585-23.49150141647.0610.06313.96785056.29714614CS
156-6.3485-54.02978723411.7523.393.96843728.10697954CS
260-6.3485-54.02978723411.7523.393.96843728.10697954CS

OBIO - Frequently Asked Questions (FAQ)

What is the current Orchestra BioMed share price?
The current share price of Orchestra BioMed is US$ 5.4015
How many Orchestra BioMed shares are in issue?
Orchestra BioMed has 38,013,526 shares in issue
What is the market cap of Orchestra BioMed?
The market capitalisation of Orchestra BioMed is USD 206.79M
What is the 1 year trading range for Orchestra BioMed share price?
Orchestra BioMed has traded in the range of US$ 3.96 to US$ 10.0631 during the past year
What is the PE ratio of Orchestra BioMed?
The price to earnings ratio of Orchestra BioMed is -4.18
What is the cash to sales ratio of Orchestra BioMed?
The cash to sales ratio of Orchestra BioMed is 74.38
What is the reporting currency for Orchestra BioMed?
Orchestra BioMed reports financial results in USD
What is the latest annual turnover for Orchestra BioMed?
The latest annual turnover of Orchestra BioMed is USD 2.76M
What is the latest annual profit for Orchestra BioMed?
The latest annual profit of Orchestra BioMed is USD -49.12M
What is the registered address of Orchestra BioMed?
The registered address for Orchestra BioMed is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1 1104
Which industry sector does Orchestra BioMed operate in?
Orchestra BioMed operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDMDBaird Medical Investment Holdings Ltd
US$ 9.6097
(77.30%)
14.41M
NUKKNukkleus Inc
US$ 33.20
(61.71%)
16.69M
CRKNCrown Electrokinetics Corporation
US$ 0.1216
(52.57%)
352.75M
GSITGSI Technology
US$ 4.02
(46.18%)
73.66M
VSVersus Systems Inc
US$ 2.7299
(42.18%)
61.32M
PMAXPowell Max Ltd
US$ 0.65
(-21.67%)
2.65M
LGCBLinkage Global Inc
US$ 0.2985
(-19.32%)
563.12k
AENTAlliance Entertainment Holding Corporation
US$ 4.8101
(-19.02%)
119.32k
SHOTWSafety Shot Inc
US$ 0.1855
(-17.56%)
3.36k
BLRXBioLineRx Ltd
US$ 0.1009
(-17.23%)
21.81M
GCTKGlucoTrack Inc
US$ 0.10205
(38.28%)
406.95M
CRKNCrown Electrokinetics Corporation
US$ 0.1216
(52.57%)
352.75M
TGLTreasure Global Inc
US$ 0.2755
(28.56%)
250.05M
RIMEAlgorhythm Holdings Inc
US$ 0.0425
(0.47%)
240.37M
NVDANVIDIA Corporation
US$ 138.0002
(3.32%)
114.41M

Your Recent History

Delayed Upgrade Clock